NCT06858501View on ClinicalTrials.gov

Comparing 123I-MIBG and 18F-MFBG Imaging in Patients With Newly Diagnosed, High Risk Neuroblastoma

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

December 22, 2025

Primary Completion Date

December 20, 2028

Study Completion Date

December 20, 2028

Conditions
GanglioneuroblastomaGanglioneuroblastoma, NodularHigh Risk Neuroblastoma
Interventions
PROCEDURE

Biospecimen Collection

Undergo blood sample collection

PROCEDURE

Computed Tomography

Undergo PET/CT

RADIATION

Florbenguane F18

Given IV

PROCEDURE

Magnetic Resonance Imaging

Undergo PET/MRI

PROCEDURE

Positron Emission Tomography

Undergo PET/CT or PET/MRI

OTHER

Questionnaire Administration

Ancillary studies

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Children's Oncology Group

NETWORK